These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18752390)

  • 1. Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination.
    Studdiford J; Lamb K; Horvath K; Altshuler M; Stonehouse A
    Pharmacotherapy; 2008 Sep; 28(9):1194-7. PubMed ID: 18752390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neck and supraclavicular lymphadenopathy secondary to 9-valent human papillomavirus vaccination.
    Pereira MP; Flores P; Neto AS
    BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31694828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythema multiforme following vaccination for human papillomavirus.
    Katoulis AC; Liakou A; Bozi E; Theodorakis M; Alevizou A; Zafeiraki A; Mistidou M; Stavrianeas NG
    Dermatology; 2010; 220(1):60-2. PubMed ID: 19887766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic diagnosis of lymph node biopsies.
    Tiwari M; Aryal G; Shrestha R; Rauniyar SK; Shrestha HG
    Nepal Med Coll J; 2007 Dec; 9(4):259-61. PubMed ID: 18298016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the histopathologic patterns of superficial lymph node diseases, in Lagos (1991-2004).
    Anunobi CC; Banjo AA; Abdulkareem FB; Daramola AO; Abudu EK
    Niger Postgrad Med J; 2008 Dec; 15(4):243-6. PubMed ID: 19169341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses.
    David MP; Van Herck K; Hardt K; Tibaldi F; Dubin G; Descamps D; Van Damme P
    Gynecol Oncol; 2009 Dec; 115(3 Suppl):S1-6. PubMed ID: 19217149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic HPV-related cervical adenocarcinomas presenting with thromboembolic events (Trousseau Syndrome): clinicopathologic characteristics of 2 cases.
    Veras E; Srodon M; Neijstrom ES; Ronnett BM
    Int J Gynecol Pathol; 2009 Mar; 28(2):134-9. PubMed ID: 19188822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus vaccine acceptability among young adult men.
    Gerend MA; Barley J
    Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions.
    Siegrist CA; Lewis EM; Eskola J; Evans SJ; Black SB
    Pediatr Infect Dis J; 2007 Nov; 26(11):979-84. PubMed ID: 17984802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus vaccine: a paradigm shift for pediatricians.
    Jenson HB
    Curr Opin Pediatr; 2009 Feb; 21(1):112-21. PubMed ID: 19242247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer prevention in the human papilloma virus vaccine era.
    Ghazal-Aswad S
    Ann N Y Acad Sci; 2008 Sep; 1138():253-6. PubMed ID: 18837904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccines.
    Satyaprakash A; Creed R; Ravanfar P; Mendoza N
    Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparing for HPV vaccination in South Africa: key challenges and opinions.
    Harries J; Moodley J; Barone MA; Mall S; Sinanovic E
    Vaccine; 2009 Jan; 27(1):38-44. PubMed ID: 18977271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in knowledge of women about cervix cancer, human papilloma virus (HPV) and HPV vaccination due to introduction of HPV vaccines.
    Donders GG; Bellen G; Declerq A; Berger J; Van Den Bosch T; Riphagen I; Verjans M
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):93-5. PubMed ID: 19409688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insufficient basis for the inclusion of Human papillomavirus vaccination in the National Immunisation Programme in The Netherlands].
    de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2001-4. PubMed ID: 18825885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadrivalent HPV vaccination reactions--more hype than harm.
    Douglas RJ
    Aust Fam Physician; 2009 Mar; 38(3):139-42. PubMed ID: 19283255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV vaccination catch up program - utilisation by young Australian women.
    Weisberg E; Bateson D; McCaffery K; Skinner SR
    Aust Fam Physician; 2009; 38(1-2):72-6. PubMed ID: 19283241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians.
    Kahn JA; Cooper HP; Vadaparampil ST; Pence BC; Weinberg AD; LoCoco SJ; Rosenthal SL
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2325-32. PubMed ID: 19661092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.